These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Exacerbation of ventricular tachycardia by tocainide. Cheesman M; Ward DE Clin Cardiol; 1985 Jan; 8(1):47-50. PubMed ID: 3917881 [TBL] [Abstract][Full Text] [Related]
5. Paranoid psychoses induced by tocainide. Harrison DJ; Wathen CG Br Med J (Clin Res Ed); 1984 Mar; 288(6422):1010-1. PubMed ID: 6423157 [No Abstract] [Full Text] [Related]
6. Short- and long-term therapy with tocainide for malignant ventricular tachyarrhythmias. Hohnloser SH; Lange HW; Raeder EA; Podrid PJ; Lown B Circulation; 1986 Jan; 73(1):143-9. PubMed ID: 3079677 [TBL] [Abstract][Full Text] [Related]
7. Possible proarrhythmic effects of tocainide in dilated cardiomyopathy. Brownstein SL; Constantin L; Kienzle MG; Martins JB Pacing Clin Electrophysiol; 1988 Jul; 11(7):1032-5. PubMed ID: 2457881 [TBL] [Abstract][Full Text] [Related]
8. A seizure induced by concurrent lidocaine-tocainide therapy--is it just a case of additive toxicity? Forrence E; Covinsky JO; Mullen C Drug Intell Clin Pharm; 1986 Jan; 20(1):56-9. PubMed ID: 3080299 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias. Ryan W; Engler R; LeWinter M; Karliner JS Am J Cardiol; 1979 Feb; 43(2):285-91. PubMed ID: 760482 [TBL] [Abstract][Full Text] [Related]
10. Torsade de pointes: successful acute control by lidocaine and chronic control by tocainide in two patients--one each with acquired long QT and the congenital long QT syndrome. Bansal AM; Kugler JD; Pinsky WW; Norberg WJ; Frank WE Am Heart J; 1986 Sep; 112(3):618-21. PubMed ID: 3092611 [No Abstract] [Full Text] [Related]
11. Effects of tocainide studied with programmed electrical stimulation of the heart in patients with reentrant tachyarrhythmias. Waleffe A; Bruninx P; Mary-Rabine L; Kulbertus HE Am J Cardiol; 1979 Feb; 43(2):292-9. PubMed ID: 760483 [No Abstract] [Full Text] [Related]
12. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study. Mahapatra RK; Mahapatra D Angiology; 1986 Apr; 37(4):285-93. PubMed ID: 2424347 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery. Morganroth J; Panidis IP; Harley S; Johnson J; Smith E; MacVaugh H Am J Cardiol; 1984 Dec; 54(10):1253-8. PubMed ID: 6439023 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease. Reiter MJ; Easley AR; Mann DE Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228 [TBL] [Abstract][Full Text] [Related]
15. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone. Kreeger RW; Hammill SC Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116 [TBL] [Abstract][Full Text] [Related]
16. Double-blind randomized comparison of intravenous tocainide versus lidocaine in the treatment of chronic ventricular arrhythmias. Mohiuddin SM; Hilleman DE; Mooss AN; Esterbrooks D; Sketch MH; Stengel LA; Butler ML Am Heart J; 1987 Aug; 114(2):296-302. PubMed ID: 3111238 [TBL] [Abstract][Full Text] [Related]
17. Prophylactic tocainide or lidocaine in acute myocardial infarction. Keefe DL; Williams S; Torres V; Flowers D; Somberg JC Am J Cardiol; 1986 Mar; 57(8):527-31. PubMed ID: 3082175 [TBL] [Abstract][Full Text] [Related]